Adenocarcinomas of the esophagus and adenocarcinomas of the gastroesophageal junction are postulated to be complex genetic diseases. Combined infl uences of environmental factors and genetic susceptibility likely infl uence the age at which these cancers develop. The aim of this study was to determine whether familiality and other recognized risk factors are associated with the development of these cancers at an earlier age.
INTRODUCTION
Barrett ' s esophagus (BE) and its associated cancers, esophageal adenocarcinoma (EAC) and gastroesophageal junctional adenocarcinoma (GEJAC), are associated with chronic gastroesophageal refl ux disease (GERD) (1 -3) . Furthermore, these conditions are identifi ed predominantly in white men (3 -6) . Obesity seems to be another important risk factor for these cancers, independent of GERD (7 -10) . Familial Barrett ' s esophagus (FBE), the aggregation of BE and its associated cancers in families, is a newly recognized syndrome, which suggests that BE and its associated cancers are complex genetic diseases (11 -15) .
Guidelines for screening and surveillance of BE are based on existing knowledge of these risk factors (16) . Age is also a predictor of BE and its subsequent progression to cancer, which guides diagnostic interventions. For complex diseases such as cancer, age of disease onset is generally thought to be related to combined infl uences of duration of environmental exposures and genetic susceptibility. Th us, EAC and GEJAC may develop at an earlier age in FBE families than the general population. Subjects with an inherited susceptibility may also react to exposures known to be associated with the development of metaplastic epithelium (e.g., obesity or gastroesophageal refl ux) at an earlier age. Th e identifi cation of factors that lead to earlier age of disease onset should help guide decisions regarding endoscopic screening and surveillance and also provide insights into the mechanisms of carcinogenesis.
Th e primary aim of this study was to identify risk factors associated with an earlier age of diagnosis of EAC and GEJAC. Specifi cally, the goals were to compare incidence age of diagnosis and other associated risk factors between FBE and non-FBE cancers and to determine if duration of GERD symptoms, obesity, and other recognized risk factors were associated with an earlier age of cancer diagnosis.
METHODS

Recruitment
Th is study was conducted using data obtained from an ongoing multicenter familial Barrett ' s esophagus (FBE) study registered at clinicaltrials.gov, identifi er NCT00288119, whose ultimate goal is the identifi cation of susceptibility genes. Eligible probands with established or newly diagnosed BE, EAC, or GEJAC were recruited at fi ve tertiary care academic hospitals in the US as described earlier (11, 12) . Th e BE probands themselves were not part of the present analysis but any relatives of these BE probands reported with EAC or GEJAC were included and were classifi ed as familial cancers. Recruitment periods differed at the diff erent hospitals depending on available personnel and institutional review board approval and ranged from 6 months to 7 years but included all eligible patients seen in the endoscopy suite during the respective recruitment period. Th e study group for this analysis was restricted to subjects with cancer, probands or relatives, and also included patients from an earlier published report on the prevalence of FBE (12) .
Family history
Probands, defi ned as the fi rst known aff ected member in a family, who consented to study participation were administered a FBE questionnaire that elicited information about refl ux symptoms (patterned on the validated Mayo GERQ (17) ), and other relevant exposures including obesity, and a detailed family history of BE, esophageal cancer, and other cancers. Individuals self reported their heights and weights at present and at 1, 5, 10, and 20 years before enrolment. Probands were asked to obtain permission for contacting fi rst-degree family members and any other aff ected relatives. FBE questionnaires were also administered to relatives who consented to participate. If an aff ected relative with reported cancer was deceased, then the next of kin was asked to complete relevant portions of the questionnaire, specifi cally age of cancer diagnosis. Endoscopic screening was then off ered to any family member who fi lled out the FBE questionnaire and had not had earlier upper endoscopy (18) . Attempts were made to obtain the endoscopic and histological diagnosis for all family members reported to have BE or esophageal cancer. Institutional review boards for human investigation at each individual hospital participating in the study have approved this protocol.
Defi nitions
For probands and relatives, the defi nition of BE required clear documentation of measurements of aff ected segment of tubular esophagus in the endoscopy report and documented presence of intestinal metaplasia on biopsy. Biopsies from the gastroesophageal junction containing intestinal metaplasia were classifi ed as intestinal metaplasia of the cardia and were not considered to be BE. EAC was defi ned by documented histology plus a mass predominantly involving the tubular esophagus and GEJAC was defi ned by documented histology plus a mass predominantly involving the gastroesophageal junction. All biopsies from within the institution were reviewed by a designated gastrointestinal pathologist. Endoscopy and pathology records were requested from outside hospitals for relatives reported to have esophageal cancer or BE. Body mass index (BMI = weight per height 2 in units of kg m -2 ) was calculated and obesity was defi ned as BMI ≥ 30. Probands and families were classifi ed as confi rmed FBE diagnosis when the diagnosis of BE, EAC, or GEJAC was ascertained in the proband and at least one aff ected relative. Probands were classifi ed as having non-familial disease if they reported no aff ected family member and BE was not diagnosed in any family member who subsequently agreed to a screening endoscopy. Probands and families were classifi ed as possible FBE diagnosis when the proband reported an aff ected family member but medical records on the family member could not be obtained. Probands were classifi ed as false positive FBE diagnosis when the proband reported an aff ected family member with BE or EAC / GEJAC who did not meet ascertainment criteria for BE or EAC / GEJAC, respectively, upon review of medical records.
Probands and family members with EAC / GEJAC who were members of confi rmed or possible FBE families were grouped as " FBE " and probands with no family history or false positive FBE diagnosis were grouped as " non-FBE " for analysis.
Sample size calculations were carried out to test a primary hypothesis of a diff erence in incidence age of cancers for individuals with a family history compared with individuals without a family history. A s.d. of 12.21 years for age-at-onset was assumed using information from the 1996 Surveillance, Epidemiology and End Results (SEER) tumor registry on rates of EAC given age and gender categories (for whites only). As it is diffi cult to determine FBE / " sporadic " status with certainty without identifi cation of the susceptibility gene(s), power was computed assuming misclassifi cation rates from 0 to 20 % in both directions. Assuming a minimum sample size of 80 FBE cancers, the power is ≥ 65 % to detect a diff erence in mean ageat-onset of 5 years, and ≥ 99 % to detect a diff erence in mean age-at-onset of 10 years for misclassifi cation rates up to 20 % at a signifi cance level ( ) of 0.05. Th e goal was to accrue a minimum of 80 cancers in the FBE group for whom the incidence age of cancer diagnosis was available.
Only subjects with cancer, EAC or GEJAC, were included in the analysis. Diff erences in age at diagnosis and other risk factors such as GERD symptoms, gender, race, smoking, and obesity were compared between the FBE cancer group and the non-FBE cancer group. Fisher ' s-exact tests were used to compare categorical variables generating 2-sided P values and the Kruskal -Wallis test was used to compared average age at diagnosis generating two-sided P values between the FBE cancers and non-FBE cancers groups. P values < 0.05 were considered statistically signifi cant. Obesity was initially examined by comparing the calculated current BMI (in kg m -2 ), and BMI reported 1, 5, 10, and 20 years before diagnosis between groups. Obesity was then defi ned as BMI ≥ 30 and compared as a binary categorical variable between the FBE and non-FBE groups. In order to investigate which relevant clinical and / or demographic variables are associated with age at esophageal cancer diagnosis, mixed linear models were used. Th ese models allow for the specifi cation of and accounting for familial correlation structure of BE / EAC / GEJAC in all univariable and multivariable models of age at esophageal cancer diagnosis. Akaike ' s Information Criterion (AIC), defi ned as the − 2 log likelihood of the model plus two times the number of estimated parameters, was calculated and used to compare statistical models. Lower values of AIC signify the better fi tting preferred models when comparing models that have used the same number of subject information. Statistical Analysis Soft ware (Version 9.1, SAS, Inc., Cary, NC, USA, 2003) were used for analyses and the Statistical Package for Social Sciences soft ware (SPSS, Inc. for Windows, Version 11.0, Chicago, IL) was used for generating graphs.
RESULTS
Classifi cation of esophageal and junctional cancers
Th e familial study from which the study cohort is derived successfully recruited 1,011 of 1,916 (53 % ) eligible probands with BE, EAC, or GEJAC seen during the study period. A total of 356 individuals with cancer (256 EAC, 45 GEJAC, and 55 whose location could not be clearly determined) were identifi ed. Questionnaires were completed by 192 subjects in the non-FBE cancer group and 56 subjects in the FBE cancer group. Th e non-FBE cancers group consisted of 216 probands with cancer who had no family history of BE or EAC / GEJAC. Th e 140 subjects in the FBE cancers group consisted of 54 probands with EAC / GEJAC and 86 relatives reported to have esophageal cancer. Th ere were no signifi cant diff erences in gender or race between the non-FBE and the FBE group. Stage information was available for 147 cancers in the non-FBE group and 44 cancers in the FBE group ( Table 1 ) . Th ere was no signifi cant diff erence in cancer stage distribution between the two groups.
Age of cancer diagnosis in familial cancers
Age of cancer diagnosis was known in 320 subjects with mean age = 62.1 years (s.d. = 12.9 years, range, 22 -89 years). Th ere was no signifi cant diff erence in age of cancer diagnosis between the non-FBE vs. the FBE group, mean age 61.9 vs. 62.6 years, P = 0.70 ( Table 1 and Figure 1a ). Th ere was also no signifi cant diff erence in age of cancer diagnosis when the non-FBE group was compared with those in the FBE group whose familial status was confi rmed, mean age 61.9 vs. 61.1 years, P = 0.18 ( Figure 1b ) . Th e study cohort included 27 cancers that occurred in families with three or more aff ected individuals. Th e mean age of diagnosis of cancer for these 27 subjects was 64.8 years and was no earlier than the remainder of the group.
Symptoms and exposures in familial cancers
Th ere was no signifi cant diff erence in the proportion of non-FBE cancer patients and the FBE cancer patients who reported heartburn (60 % vs. 67 % , P = 0.44) or regurgitation (64 % vs. 66 % , P = 0.88) before cancer diagnosis ( Table 1 ) . Th ere were also no signifi cant diff erences in frequency, duration, or severity of heartburn or regurgitation as assessed by the FBE questionnaire between the non-FBE and the FBE cancer groups. Weight and height measurements were obtained on 198 subjects in the non-FBE group and 54 subjects in the FBE group. At time of diagnosis, 36 (16.7 % ) of the non-FBE subjects were obese vs. 17 (12.1 % ) of the FBE group, P = 0.24 ( Table 1 ) . Furthermore, there was no signifi cant diff erence in the percent of subjects who were obese at 1 year, 5 years, 10 years, and 20 years before diagnosis, between the non-FBE and FBE cancer groups. Th e proportions of non-FBE and FBE cancers that smoked (73 % vs. 74 % , P = 1.0) and drank alcohol (83 % vs. 80 % , P = 0.68) were also not signifi cantly diff erent.
Effect of obesity and other risk factors on age at cancer diagnosis
In order to further examine the association between known risk factors for BE associated cancers and age at cancer diagnosis, mixed linear models were used to account for familial correlation of BE and cancer ( Table 2 ). In univariable analyses, family history of BE was not associated with age of cancer diagnosis, neither was heartburn duration, regurgitation duration or trouble swallowing duration. However, obesity (BMI ≥ 30) 1 year before, 5 years before and 10 years before diagnosis were signifi cantly associated with a younger age at cancer diagnosis ( Table 2 ). Mean age of cancer diagnosis in patients who were obese 1 year before cancer diagnosis was 58.99 years compared with 63.6 years for those who were not obese ( Figure 2 ). Multivariable modeling ( Table 3 ) showed an 
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Assessment of Familiality, Obesity, and Other Risk Factors associated adenocarcinomas, which could partially explain the rising incidence of these diseases in the US and other countries (7 -10,19 -21) . Although obesity also contributes to gastroesophageal refl ux (22 -24) , obesity is clearly an independent risk factor for EAC (7 -10) . Central adiposity has also recently been shown to be independently associated with BE (19 -21) . In this study, obesity 1 year before diagnosis of cancer was signifi cantly associated with a diagnosis of cancer at an earlier age. Th is association was further strengthened aft er adjustment for heartburn and regurgitation symptom duration. In contrast, the duration of GERD symptoms by themselves were not signifi cant predictors of earlier age of cancer diagnosis. In addition, other known BE / EAC risk factors such as male gender, white race, and smoking were not signifi cantly associated with family history or earlier age at cancer diagnosis. Th e association of obesity with earlier age of cancer diagnosis could be related to a dietary factor, obesity induced gastroesophageal refl ux, or alterations in metabolic mediators. Obesity has been proposed to be carcinogenic for a variety of cancers (25) . General molecular mechanisms for obesity induced carcinogenesis include oxidative stress / DNA damage, non-infl ammatory changes in immune function, infl ammatory mediators, hormones and growth factors, and metabolic detoxifi cation factors. Th e specifi c molecular mechanisms that lead to the development of esophageal and gastroesophageal junctional cancers at an earlier age in the presence of obesity need to be elucidated. It is increasingly apparent that obesity is an important risk factor for esophageal carcinogenesis that should infl uence screening and surveillance strategies.
Familial aggregation oft en implies a genetic susceptibility to disease but may also be caused by a common environmental exposure within families. In general, familial cancers are presumed to be complex genetic traits, which in some cancers may manifest with an early age of disease onset. Th e manifestation of a putative susceptibility gene depends on trait defi nition. Inclusion of Barrett ' s esophagus, adenocarcinoma of the esophagus, and adenocarcinoma of the gastroesophageal junction as part of a single complex trait is justifi ed because of strong evidence that nearly all adenocarcinomas of the esophagus and a substantial proportion of adenocarcinomas of the gastroesophageal junction arise in Barrett ' s epithelium (1,2,4,26 -31) . Th is study shows that age of disease onset for FBE cancers is the same as non-FBE cancers.
Familial aggregation of BE and its associated cancers could represent a genetic susceptibility to metaplastic transformation of the esophagus, a genetic susceptibility to a recognized risk factor such as GERD (1 -4) or obesity (7 -10) , or a common environmental exposure such as smoking or alcohol (32 -34) . Th e proportion of FBE cancers reporting GERD symptoms was the same as the proportion of non-FBE cancers with GERD symptoms, suggesting that FBE does not represent a genetic predisposition to gastroesophageal refl ux. Our earlier study that measured the prevalence of FBE raised the possibility that FBE probands with cancer may be less obese than non-FBE probands with cancer (12) . However, the present study, which had a larger sample size and included additional relatives of association between obesity (BMI ≥ 30) 1 year before diagnosis and younger age at cancer diagnosis that was further strengthened aft er adjustment for heartburn duration and regurgitation duration (BMI < 30 age at diagnosis 63.68 compared with BMI ≥ 30 age at diagnosis 58.81), whereas this multivariable eff ect was not seen with obesity (BMI ≥ 30) 5 years or 10 years before diagnosis. Th erefore the multivariable model with obesity 1 year before diagnosis and heartburn duration and regurgitation duration provided the best fi tting model for age at cancer diagnosis in this study population. Th ese models were also run removing the 45 cases of JCA cancer and the results remained the same (data not shown).
DISCUSSION
Obesity is increasingly recognized as an important risk factor for the development of Barrett ' s esophagus (BE) and its 
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Assessment of Familiality, Obesity, and Other Risk Factors transformation it is less important in the subsequent progression to cancer. Th e results of this study need to be interpreted in the context of the limitations of the study design. Data on several variables were missing (smoking and alcohol history were unavailable in nearly a third of the subjects, birth year was unavailable in nearly half the subjects) for a number of study subjects (see Table 2 ). Missing data regarding deceased subjects could lead to biased results, especially if there was a unrecognized systematic misclassifi cation of exposures reported by proxy respondents. However, it is unlikely that age of cancer diagnosis would be misreported, even by proxy respondents. Obesity 1 year before diagnosis or longer was used for analysis on the assumption that the majority of weight loss associated with cancer diagnosis was within the fi rst year before diagnosis. Obesity was assessed by calculated BMI but we had no information on central adiposity, which may be a better measure of the type of obesity that predisposes individuals to BE (19 -21) . Individuals self reported data collected by the FBE questionnaire including height and weight in the years preceding study enrollment. Overweight individuals are known to underreport weight, which might lead to an underestimation of obesity in this study (35) . Data on GERD symptoms were also self reported and were collected using questions from the validated Mayo GERQ developed by Locke et al. (17) . It is also possible that birth year could be associated with both refl ux symptoms and obesity as the incidence of both of these traits has increased in recent decades. In our data we were missing birth year information on half of our subjects therefore meaningful birth year eff ects could not be examined.
Th is study cohort of cancer patients is part of an ongoing family study. Th erefore, it was necessary to account for familial correlations in the statistical analysis. Mixed linear models were used because they allowed for the specifi cation of and accounting for family correlation structure in our univariable and multivariable modeling of age at cancer diagnosis in this study population. Subjects with a reported aff ected relative whose diagnosis could not be verifi ed despite multiple attempts probands and probands did not fi nd a signifi cant diff erence. Th us, FBE is unlikely to represent a genetic susceptibility to obesity. Finally, this study also found no diff erence in smoking or alcohol use between FBE and non-FBE cancers.
GERD is clearly associated with BE and its associated cancers (1 -4) . Chronic gastroesophageal refl ux is believed to be essential to the process of metaplastic transformation. However, it is not clear what role persistent gastroesophageal refl ux plays in the progression from metaplasia to cancer once metaplasia has developed. Th e duration of GERD symptoms was not found to be associated with an earlier age of cancer diagnosis in this study. Th e study was primarily powered to investigate the association of age of cancer diagnosis with familiality. It might not have suffi cient power to detect an association with GERD. GERD symptoms are also an indirect marker of GERD exposure and might not refl ect the extent of exposure. Another possible explanation that needs to be explored is that although GERD plays an important role in the process of metaplastic were classifi ed as part of the FBE group because we have found the false positive rate of reported family history to be < 10 % 12 . Th e results did not change when the analysis was restricted to the subset of FBE patients in whom the diagnosis in the aff ected relative was confi rmed ( Figure 1b ) . Th e multivariable results for age at cancer diagnosis also did not change if adenocarcinomas of the gastroesophageal junction were excluded from analysis (data not shown). Th e inclusion of these cancers might lead to inclusion of a few cancers that were truly of gastric origin but this would likely lead to an attenuation of fi ndings. Probands and relatives were able to provide information about age of cancer diagnosis for deceased relatives with cancer; however, exposure information was generally missing for these deceased individuals. Complex traits such as FBE may be genetically heterogeneous. Until and unless the genetic variant (s) that confers susceptibility to the development of BE is (are) identifi ed, there is a strong likelihood that some individuals in this study without a genetic susceptibility were misclassifi ed as FBE and others with a genetic susceptibility were misclassifi ed as non-FBE ( " apparently sporadic " ). Th e sample size was suffi cient for at least a 20 % rate of misclassifi cation. Of course, there may be selected variants that are manifested at an earlier age. Th erefore, if FBE is truly a complex genetic disease, it is unlikely that any major susceptibility gene is manifested at an earlier age. In summary, this study found that obesity was associated with earlier age of cancer diagnosis. Th e molecular mechanisms by which obesity contributes to the development of BE and its progression to cancer need to be investigated. Th ere were no signifi cant diff erences in age of disease onset and other risk factors between FBE and non-FBE cancers. Within the limitations of unmeasurable misclassifi cation, FBE is unlikely to represent a genetic susceptibility to obesity or gastroesophageal refl ux. Th e trait is proposed to be a manifestation of genetic variant (s) that confer a susceptibility to metaplastic transformation of the esophageal epithelium perhaps in the presence of infl ammation caused by gastroesophageal refl ux and / or obesity. Furthermore, obesity might contribute to the progression of BE to cancer by undefi ned mechanisms in susceptible individuals. Based on the results of this study, screening and surveillance practices do not need to be modifi ed for age in individuals who are members of FBE families.
